Press / Publications

The BMBF-funded project CTCelect is making significant progress in the investigation of isolated circulating tumor cells (CTCs). In an integrated approach including user surveys as well as ethical and legal aspects, the consortium has developed and tested a system for CTC isolation over the last four years, which is robust and easy to use for the user and is based on the patient-friendly collection of a single blood sample. With the help of the development status of the open and thus flexibly applicable CTCelect system validated on real samples, extensive new results in medical research are made possible.

As a pioneer in applied research, the Fraunhofer-Gesellschaft brings together the expertise of 23 separate Fraunhofer facilities to develop new development and production technologies for innovative cell and gene therapeutics, as well as vaccines, in the “Production for Intelligent Medicine” innovation cluster. As a first step of the project, a concept for a modular pilot plant for the automatic production of these therapeutics is to be developed combining both Industry 4.0 and Health 4.0.

Fraunhofer IMM participates in a maritime innovation project looking to install the world’s first high-power fuel cell to be powered by green ammonia on a vessel. The project has been awarded 10 million Euro funding from the European Union.

Launch of a new H2020 project aiming to incite a transition to a more flexible and sustainable chemistry by taking novel integrated upstream and downstream processing paths involving flow chemistry and membrane technology in two chemo-enzymatic processes to an industrial level.

Based on the long term experience in micro fluidics and lab-on-a-chip systems Fraunhofer IMM will develop a microfluidic cartridge which can perform a fully automatic complete sample preparation and all required analytical steps once inserted into the instrument.

The Fraunhofer ICT -IMM Institute and Döhler are collaborating in the development of a new microbiological detection method based on microfluidics.

Fraunhofer ICT-IMM is coordinating a national research cooperation dealing with the development of a microreactor system for the environmentally friendly utilization of CO2 by means of sunlight.

The research partners Volvo Technology (Sweden), Johnson-Matthey (United Kingdom), Modelon AB (Sweden), PowerCell AB (Sweden), Jožef Stefan Institute (Slovenia), Forschungszentrum Jülich (Germany) and Fraunhofer ICT-IMM (Germany) have reached their final goal by the end of the FCGEN project: they have developed a diesel-powered fuel cell system and successfully demonstrated its functionality in autonomous operation mode.

Fraunhofer ICT-IMM meets representatives of Canadian Embassy and Granting Agency

Medical science today is better developed than ever and pharmaceutical companies are continuously working on innovations. The composition of medicines, their purity and of course their constant quality are of utmost importance. At this point NMR spectroscopy, one of the most important analytical methods of organic chemistry and a standard method for the structure elucidation of chemical compounds, may help.